Buy Albireo Pharma Stock | ALBO Stock Price & Latest News | Public.com
ALBO

Albireo Pharma

$0.00 (0.00%)Today
    View Albireo Pharma (ALBO) stock trends here

    About ALBO

    Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. It pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.65
    -1.31
    -1.96
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.80

    Actual EPS
    Q1 2021

    Stats

    Market Cap$683,69M
    Volume39,87k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$49.00
    1 Year Low$11.26
    Open$35.53
    High$36.69
    Low$34.50

    Buy any stock with any amount of money.

    Download the App
    Download the app